Upon completion of this course, the dental professional should be able to:
- Discuss in general terms the approval process of new drugs and its limitations as they relate to ADRs.
- Discuss “on-target,” “off-target,” and cytotoxic mechanisms of ADRs.
- Develop a clinical frame of reference related to ADRs.
- Discuss the spectrum of potential ADRs affecting the head and neck area and various organ systems associated with dental therapeutics and the top 200 drugs dispensed by U.S. community pharmacies.